← boothcheck

ELV vs MOH stock comparison

ELEVANCE HEALTH, INC. vs MOLINA HEALTHCARE, INC., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Neither Medicaid-exposed insurer grew into this year gracefully, but the damage differs by an order: Elevance still earns a 2.6% net margin and trades at 16.8 times earnings, while Molina's margin compressed to 0.42% and its multiple is unquotable. Scale is the buffer, $87B of Elevance against $12B of Molina, and mix: Elevance's Blue Cross commercial book cushions its government exposure, Molina is government almost entirely. Elevance pays a 1.5% dividend and shows a 7.4% free-cash figure, float-flattered as always; Molina's 2.1% has the same asterisk. The pair prices the same rate-reset storm from two exposures: diversified and dinged against concentrated and capsized.

Comparison updated 2026-07-10.

ELV vs MOH: the numbers

MetricELVMOH
Price$395.20$229.88
Market cap$87.1B$11.7B
SectorManaged CareManaged Care
StageMatureMature
P/E16.8
P/B1.982.87
P/S0.430.26
EV/EBITDA17.916.5
Revenue growth+9.5%+8.0%
Operating margin4.2%0.8%
Net margin2.6%0.4%
Return on equity11.9%4.6%
Return on assets4.2%1.1%
Return on invested capital6.2%2.6%
FCF yield7.4%2.1%
Dividend yield1.5%
Debt / equity0.720.92
Current ratio1.481.63
Altman Z (solvency)2.894.02
Piotroski F (quality)7 / 97 / 9
Full ELV report → Full MOH report →
Get boothcheck's read on ELV and MOH, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.